OrbiMed’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-77,800
Closed -$7.22M 143
2014
Q4
$7.22M Sell
77,800
-33,300
-30% -$3.09M 0.07% 97
2014
Q3
$7.64M Hold
111,100
0.08% 96
2014
Q2
$11.6M Hold
111,100
0.14% 70
2014
Q1
$9.22M Sell
111,100
-18,900
-15% -$1.57M 0.11% 86
2013
Q4
$8.41M Hold
130,000
0.12% 80
2013
Q3
$8.24M Buy
+130,000
New +$8.24M 0.15% 76